logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Joseph J. DeGeorge

merck & company

21H指数
78论文数
1.9K被引数
收录论文 20
发表时间
logo
Fit for Purpose Assessment: A New Direction for IACUCs
errILAR JOURNAL
IF3.1
err2022-05-04
err4
errOAAI
errKinter, Lewis B.; Johnson, David K.; Weichbrod, Robert H.; Prentice, Ernest D.; Simmonds, Richard C.; Houghton, Paul W.; Whitney, Robert A., Jr.; DeGeorge, Joseph; DeHaven, W. Ron; Kramer, Klaas; DeTolla, Louis
err分享
err收藏
A Brief History of Use of Animals in Biomedical Research and Perspective on Non-Animal Alternatives在生物医学研究中使用动物的简史和非动物替代品的观点
errILAR JOURNAL
IF3.1
err2021-06-25
err17
errOAAI
errKinter, Lewis B.; DeHaven, Ron; Johnson, David K.; DeGeorge, Joseph J.
err分享
err收藏
Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2019-10-01
err1
PREAI
errAndrews, Paul A.; McNerney, Mary Ellen; DeGeorge, Joseph J.
err分享
err收藏
Analysis of exposure margins in developmental toxicity studies for detection of human teratogens
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2019-07-01
err13
PREAI
errAndrews, Paul A.; Blanset, Diann; Costa, Priscila Lemos; Green, Martin; Green, Maia L.; Jacobs, Abigail; Kadaha, Rajkumar; Lebron, Jose A.; Mattson, Britta; McNerney, Mary Ellen; Minck, Daniel; Oliveira, Luana de Castro; Theunissen, Peter T.; DeGeorge, Joseph J.
err分享
err收藏
An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2017-12-29
err3
PREAI
errDeGeorge, Joseph; Robertson, Sarah; Butler, Lynne; Derzi, Mazin; Stoch, S. Aubrey; Diaz, Dolores; Hartke, James; Guzzie-Peck, Peggy; Mortimer-Cassen, Elisabeth; Bogdanffy, Matthew; Will, Yvonne; Greene, Nigel
err分享
err收藏
Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspective
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2017-07-01
err28
PREAI
errButler, Lynne D.; Guzzie-Peck, Peggy; Hartke, James; Bogdanffy, Matthew S.; Will, Yvonne; Diaz, Dolores; Mortimer-Cassen, Elisabeth; Derzi, Mazin; Greene, Nigel; DeGeorge, Joseph J.
err分享
err收藏
Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry
errSCIENTIFIC REPORTS
IF3.9
err2017-03-22
err13
errOAAI
errLagrutta, Armando; Regan, Christopher P.; Zeng, Haoyu; Imredy, John P.; Koeplinger, Kenneth; Morissette, Pierre; Liu, Liping; Wollenberg, Gordon; Brynczka, Christopher; Lebron, Jose; DeGeorge, Joseph; Sannajust, Frederick
err分享
err收藏
Role of chronic toxicology studies in revealing new toxicities
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2016-12-01
err11
PREAI
errGalijatovic-Idrizbegovic, Alema; Miller, Judith E.; Cornell, Wendy D.; Butler, James A.; Wollenberg, Gordon K.; Sistare, Frank D.; DeGeorge, Joseph J.
err分享
err收藏
Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells
errTOXICOLOGY AND APPLIED PHARMACOLOGY
IF3.4
err2016-10-01
err19
PREAI
errLagrutta, Armando; Zeng, Haoyu; Imredy, John; Balasubramanian, Bharathi; Dech, Spencer; Lis, Edward; Wang, Jixin; Zhai, Jin; DeGeorge, Joseph; Sannajust, Frederick
err分享
err收藏
Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeys
errHEPATOLOGY
IF15.8
err2016-08-23
err22
errOAAI
errRegan, Christopher P.; Morissette, Pierre; Regan, Hillary K.; Travis, Jeffery J.; Gerenser, Pamela; Wen, Jianzhong; Fitzgerald, Kevin; Gruver, Shaun; DeGeorge, Joseph J.; Sannajust, Frederick J.
err分享
err收藏
Toxicogenomics in drug development: a match made in heaven?
errEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
IF3.4
err2016-04-21
err14
errOAAI
errQin, Chunhua; Tanis, Keith Q.; Podtelezhnikov, Alexei A.; Glaab, Warren E.; Sistare, Frank D.; DeGeorge, Joseph J.
err分享
err收藏
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2014-10-01
err22
errOAAI
errSewell, Fiona; Chapman, Kathryn; Baldrick, Paul; Brewster, David; Broadmeadow, Alan; Brown, Paul; Burns-Naas, Leigh Ann; Clarke, Janet; Constan, Alex; Couch, Jessica; Czupalla, Oliver; Danks, Andy; DeGeorge, Joseph; de Haanm, Lolke; Hettinger, Klaudia; Hill, Marilyn; Festag, Matthias; Jacobs, Abby; Jacobson-Kram, David; Kopytek, Stephan; Lorenz, Helga; Moesgaard, Sophia Gry; Moore, Emma; Pasanen, Markku; Perry, Rick; Ragan, Ian; Robinson, Sally; Schmitt, Petra M.; Short, Brian; Lima, Beatriz Silva; Smith, Diane; Sparrow, Sue; van Bekkum, Yvette; Jones, David
err分享
err收藏
Safety Assessment of Drug Metabolites: Implications of Regulatory Guidance and Potential Application of Genetically Engineered Mouse Models that Express Human P450s
errCHEMICAL RESEARCH IN TOXICOLOGY
IF3.8
err2009-01-26
err25
PREAI
errPowley, Mark W.; Frederick, Clay B.; Sistare, Frank D.; DeGeorge, Joseph J.
err分享
err收藏
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2006-04-01
err397
PREAI
errMüller, L; Mauthe, RJ; Riley, CM; Andino, MM; De Antonis, D; Beels, C; DeGeorge, J; De Knaep, AGM; Ellison, D; Fagerland, JA; Frank, R; Fritschel, B; Galloway, S; Harpur, E; Humfrey, CDN; Jacks, AS; Jagota, N; Mackinnon, J; Mohan, G; Ness, DK; O'Donovan, MR; Smith, MD; Vudathala, G; Yotti, L
err分享
err收藏
Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err1997-04-01
err98
PREAI
errContrera, JF; Jacobs, AC; DeGeorge, JJ
err分享
err收藏
Considerations for toxicology studies of respiratory drug products
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err1997-04-01
err32
PREAI
errDeGeorge, JJ; Ahn, CH; Andrews, PA; Brower, ME; Choi, YS; Chun, MY; Du, T; Doo, YLH; McGuinn, WD; Pei, LQ; Sancilio, LF; Schmidt, W; Sheevers, HV; Sun, CJ; Tripathi, S; Vogel, WM; Whitehurst, V; Williams, S; Taylor, AS
err分享
err收藏
Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humans
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err1996-03-01
err9
PREAI
errChoudary, J; Contrera, JF; DeFelice, A; DeGeorge, JJ; Farrelly, JG; Fitzgerald, G; Goheer, MA; Jacobs, A; Jordan, A; Meyers, L; Osterberg, R; Resnick, C; Sun, CJ; Temple, RJ
err分享
err收藏
DIFFERENCES IN RATES OF INCORPORATION OF INTRAVENOUSLY INJECTED RADIOLABELED FATTY-ACIDS INTO PHOSPHOLIPIDS OF INTRACEREBRALLY IMPLANTED TUMOR AND BRAIN IN AWAKE RATS
errCLINICAL & EXPERIMENTAL METASTASIS
IF3.2
err1994-05-01
err35
PREAI
errNARIAI, T; DEGEORGE, JJ; GREIG, NH; GENKA, S; RAPOPORT, SI; PURDON, AD
err分享
err收藏
EFFECTS OF PENTOBARBITAL ON INCORPORATION OF PLASMA PALMITATE INTO RAT-BRAIN
errANESTHESIOLOGY
IF9.1
err1994-01-01
err26
errOAAI
errYAMAZAKI, S; DEGEORGE, JJ; BELL, JM; RAPOPORT, SI
err分享
err收藏
INTRAVENOUSLY INJECTED RADIOLABELED FATTY-ACIDS IMAGE BRAIN-TUMOR PHOSPHOLIPIDS INVIVO - DIFFERENTIAL UPTAKES OF PALMITATE, ARACHIDONATE AND DOCOSAHEXAENOATE
errCLINICAL & EXPERIMENTAL METASTASIS
IF3.2
err1993-03-01
err19
PREAI
errNARIAI, T; GREIG, NH; DEGEORGE, JJ; GENKA, S; RAPOPORT, SI
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
D. I. Jones
H 指数: 125 · 论文数: 797
S
Stanley I. Rapoport
H 指数: 91 · 论文数: 743
N
Nigel H. Greig
H 指数: 87 · 论文数: 566
M
Martin Green
H 指数: 64 · 论文数: 472
S
S. C. Tripathi
H 指数: 45 · 论文数: 499
查看更多